These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7998707

  • 1. Evaluation of total serum bile acids concentration and bile acid profiles in healthy cats after oral administration of ursodeoxycholic acid.
    Day DG, Meyer DJ, Johnson SE, Weisbrode SE, Thudium DT, Rhodes DC.
    Am J Vet Res; 1994 Oct; 55(10):1474-8. PubMed ID: 7998707
    [Abstract] [Full Text] [Related]

  • 2. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
    Hess LM, Krutzsch MF, Guillen J, Chow HH, Einspahr J, Batta AK, Salen G, Reid ME, Earnest DL, Alberts DS.
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
    [Abstract] [Full Text] [Related]

  • 3. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
    Inoi J, Shimizu I, Tsuji Y, Muguruma N, Shibata H, Ito S.
    J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
    [Abstract] [Full Text] [Related]

  • 4. Effect of 6-8 weeks of oral ursodeoxycholic acid administration on serum concentrations of fasting and postprandial bile acids and biochemical analytes in healthy dogs.
    Deitz KL, Makielski KM, Williams JM, Lin H, Morrison JA.
    Vet Clin Pathol; 2015 Sep; 44(3):431-6. PubMed ID: 26274488
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of oral ursodeoxycholic acid on bile acids tolerance tests in healthy dogs.
    Abraham LA, Charles JA, Holloway SA.
    Aust Vet J; 2004 Mar; 82(3):157-60. PubMed ID: 15088982
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Conjugated bile acid profiles in serum, urine, and bile of patients with primary biliary cirrhosis under the ursodeoxycholic acid treatment].
    Aoshima M, Nakamura K, Makino I.
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):57-67. PubMed ID: 7744371
    [Abstract] [Full Text] [Related]

  • 13. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM, Campbell GR, Burke AF, Maguire OC, Rowlands BJ, FitzGerald MX, Hegarty JE.
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
    Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicelli L, Miracolo A, Simonazzi G, Colecchia A, Nigro G, Mwangemi C, Festi D, Roda E.
    Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Retrograde ileal bile acid tolerance test--experimental and clinical study].
    Taruishi M, Ashida T, Shibata Y.
    Hokkaido Igaku Zasshi; 1994 May; 69(3):574-83, 585. PubMed ID: 7927182
    [Abstract] [Full Text] [Related]

  • 20. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
    Lindblad A, Glaumann H, Strandvik B.
    Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.